Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 23, 2021

View Archived Issues

Albireo Pharma presents preclinical data on HBV entry inhibitor A-2342

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

B-cell GABA release blunts tumor immune response

New antibacterials identified at Roche

Iomx Therapeutics divulges new SIK2/SIK3 inhibitors

BeiGene describes BTK-targeting PROTACs

Jiangsu Hengrui Medicine and collaborators patent inositol derivatives

New kappa-opioid receptor agonists discovered at Medshine Discovery

Novel mouse model of focal limbic seizures with impaired behavior

PTSD model developed in Jeju minipig

Bristol Myers Squibb adds structurally diverse compounds to BET inhibitor candidates

Erythrocyte miR-210 as target for prevention of endothelial dysfunction in type 2 diabetes

KAND-145 + cisplatin reduces tumor size in disease model of chemotherapy-resistant ovarian cancer

Guard reports preclinical data on ROSgard in animal models of sepsis

Sanyou presents SYZJ-001 bispecific antibody drug against COVID-19

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...